Hypersensitivity Pneumonitis clinical trials at UCSF

1 in progress, 0 open to eligible people

Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis
Sorry, in progress, not accepting new patients
A randomized, double-blind, placebo-controlled clinical study to evaluate the safety and efficacy of 2 doses of inhaled pirfenidone (AP01) versus placebo on top of standard of care in participants with PPF over 52 weeks.
San Francisco, California and other locations

Last updated: June 17, 2026